Status:
COMPLETED
Zinc Supplementation of Imipramine Therapy
Lead Sponsor:
Polish Academy of Sciences
Collaborating Sponsors:
Jagiellonian University
Conditions:
Major Depression
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Examination of the effect of zinc supplementation on imipramine therapy in major depression.
Detailed Description
A placebo-controlled, double blind study of zinc supplementation in imipramine therapy was conducted in sixty, depressed patients fulfilling the DSM-IV criteria for major depression without psychotic ...
Eligibility Criteria
Inclusion
- patients with fulfilled DSM-IV criteria for moderate or severe depressive episode
- one week washout period without any pharmacotherapy
Exclusion
- psychotic symptoms
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2006
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00693680
Start Date
January 1 2005
End Date
April 1 2006
Last Update
June 13 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Psychiatry, Collegium Medicum, Jagiellonian University
Krakow, Poland, 31-501